Key result
Anemia poses unique risks in CVD patients due to an obligatory increase in cardiac output.
Why the study?
Anemia may present a special risk in patients with cardiovascular disease due to its obligatory increase in cardiac output, necessitating a review of physiology and therapy recommendations.
This review summarizes the physiological impact of anemia in patients with cardiovascular disease and discusses risks and therapeutic recommendations.
Answers are grounded in this paper and cite their sources.
Anemia warrants vigilance in cardiovascular patients; leaves open optimal transfusion thresholds for randomized trials.
SUMMARY Cardiovascular disease accounts for the majority of deaths each year in Westernized countries. Anemia, with its obligatory increase in cardiac output, may present a special risk in these patients. A review of the physiology of acute and chronic anemia as well as the physiology of myocardial ischemia is presented, as is also a review of the literature regarding the risks and recommendations for therapy in this group of high‐risk patients.
No takes yet. Share an insight, caveat, or question.
Joyce A. Wahr (1999) conducted a review in Anemia and Cardiovascular Disease. Anemia was evaluated. Anemia presents a special risk in patients with cardiovascular disease due to its obligatory increase in cardiac output, prompting a review of physiological risks and therapeutic recommendations.
Synapse has enriched 10 related papers. Consider them for comparative context: